S13.E5: My Life On GLP1 - Mounjaro & Fatty Liver Disease: Groundbreaking Research

from My Life On GLP1 · host Scott Johnson

74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans with fatty liver disease. From friend Jerry's diagnosis story to clinical trial data, learn why this GLP-1 medication could transform liver treatment forever. #FattyLiver #LiverDisease #Mounjaro #MASH #GLP1 https://mylifeonglp1.com/fatty-liver-disease/ https://mylifeonglp1.com/

Episode metadata supplied by the publisher feed · Published Oct 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

S13.E5: My Life On GLP1 - Mounjaro & Fatty Liver Disease: Groundbreaking Research

0:00 6:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of My Life On GLP1?

This episode is 6 minutes long.

When was this My Life On GLP1 episode published?

This episode was published on October 29, 2025.

Can I download this My Life On GLP1 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!